Clover Health Investments Corp (NASDAQ:CLOV) shares are trading lower by 1% at $7.40 in Monday's pre-market session after the company reported better-than-expected first-quarter sales results.
Clover Health reported quarterly sales of $200.30 million, which beat the analyst consensus estimate of $166.23 million.
Clover Health is a healthcare technology company. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
